Caplacizumab

From Wikipedia, the free encyclopedia
Caplacizumab ?
Monoclonal antibody
Type Whole antibody
Source Humanized
Target VWF
Clinical data
Legal status ?
Identifiers
CAS number 915810-67-2
ATC code None
Chemical data
Formula ?

Caplacizumab (INN) is a humanized monoclonal that binds to VWF.[1]

References

  1. ↑ World Health Organization (2011). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 106" (PDF). WHO Drug Information 25 (4). 
Monoclonals for bone, musculoskeletal, circulatory, and neurologic systems
Bone ("-os-", "-s(o)-")
Human ("-osu-")
Humanized ("-sozu-")
Musculoskeletal ("-mul-")
Human ("-mulu-")
Circulatory ("-c(i[r])-")
Human ("-ciru-")
Mouse ("-ciro-")
Chimeric ("-cixi-")
Humanized ("-cizu-")
Neurologic ("-ne(u)(r)-")
Human ("-neru-")
Humanized ("-nezu-"/"-neuzu-")
Angiogenesis inhibitor ("-anibi-")
Humanized ("-anibizu-")



This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.